SAO:PFRM3
Profarma Distribuidora de Produtos Farmacêuticos S.A. · SAO · Healthcare · BRL · FY for 2025
Figures on this page computed 2026-11-07 23:53 UTC
Last close
n/aBRL
Market data
We are not showing closes for this listing. A line drawn through points we do not hold would look exactly like a listing that did not move.
7.3xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- BRL
- computed
- Computed from the filing for 2025
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- BRL
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
1.0%Net margin
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- BRL
- Computed from the filing for 2025
- Computed from the filing for 2025
1.7%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- BRL
- Computed from the filing for 2025
- Computed from the filing for 2025
1.04Debt/equity
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- BRL
- Computed from the filing for 2025
- Computed from the filing for 2025
8.8%Dividend yield
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- BRL
- computed
Safety is the furthest below its sector's middle: 0.28 against 0.66 on the market's range.
Five bars, one line
lens 7 of 9Each against its own average
4 of 5 readExcept where said otherwise: Computed from the filing for 2025
- Sales1.70x
Its own average over 10 years, 6.72B.
- Profit3.34x
Its own average over 10 years, 35.6M.
- Free cash flow2.09x
Its own average over 10 years, 90.8M.
- Debt1.47x
Its own average over 10 years, 956.3M.
- Pricen/a
Its own average over 0 years. Market data
Profit is furthest from its own average, at 3.34 times.
The filed years, as a table
10Each line is 100 at 2016-12-31, the first year we hold.
| Filed year | Sales | Shares in issue |
|---|---|---|
| 2016-12-31 | 100.0 | 100.0 |
| 2017-12-31 | 100.4 | 121.3 |
| 2018-12-31 | 104.6 | 196.7 |
| 2019-12-31 | 117.5 | 205.8 |
| 2020-12-31 | 134.2 | 205.8 |
| 2021-12-31 | 157.0 | 205.8 |
| 2022-12-31 | 191.4 | 205.8 |
| 2023-12-31 | 212.1 | 205.8 |
| 2024-12-31 | 248.6 | 205.8 |
| 2025-12-31 | 280.3 | 205.8 |
How sales was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- BRL
How shares in issue was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- BRL
Figures behind the shape
Growth
15.9%faster is higher, placed against 4,950 companies as of 2026-11-07
Five-year revenue growth rate15.9%
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- BRL
- computed
Five-year EPS growth rate17.7%
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- BRL
- computed
One-year change in net income3.8%
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- BRL
- computed
Returns on capital
8.8%higher is higher, placed against 5,089 companies as of 2026-11-07
Return on invested capitaln/a
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- BRL
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Return on equity8.8%
Net Income / Shareholders' Equity x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- BRL
- Computed from the filing for 2025
- Computed from the filing for 2025
Return on assets1.9%
Net Income / Total Assets x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- BRL
- Computed from the filing for 2025
- Computed from the filing for 2025
Margins
15.3%wider is higher, placed against 3,412 companies as of 2026-11-07
Gross margin15.3%
Gross Profit / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- BRL
- Computed from the filing for 2025
- Computed from the filing for 2025
Operating margin3.3%
Operating Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- BRL
- Computed from the filing for 2025
- Computed from the filing for 2025
Net margin1.0%
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- BRL
- Computed from the filing for 2025
- Computed from the filing for 2025
Free cash flow margin1.7%
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- BRL
- Computed from the filing for 2025
- Computed from the filing for 2025
Price
7.3xcheaper is higher, placed against 4,362 companies as of 2026-11-07
Price to earnings7.3x
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- BRL
- computed
- Computed from the filing for 2025
Price to book0.6x
Price / Book Value per Share, where BVPS = Shareholders' Equity / Diluted Shares
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- BRL
- computed
- Computed from the filing for 2025
- computed
- Computed from the filing for 2025
EV to EBITDA3.5x
Enterprise Value / EBITDA, where EV = Market Cap + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- BRL
- computed
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Price to sales ratio0.1x
Market Cap / Revenue, where Market Cap = Price x Diluted Shares
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- BRL
- computed
- Computed from the filing for 2025
- Computed from the filing for 2025
Safety
1.04safer is higher, placed against 1,436 companies as of 2026-11-07
Debt to equity1.04
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- BRL
- Computed from the filing for 2025
- Computed from the filing for 2025
Current ratio1.29
Current Assets / Current Liabilities
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- BRL
- Computed from the filing for 2025
- Computed from the filing for 2025
Interest coverage1.8x
Operating Income / Interest Expense
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- BRL
- Computed from the filing for 2025
- Computed from the filing for 2025
Altman Z-Scoren/a
We do not hold this figure for this company, so there is nothing to place.
1.2 x A + 1.4 x B + 3.3 x C + 0.6 x D + 1.0 x E (A=WC/TA, B=RE/TA, C=EBIT/TA, D=MktCap/TL, E=Rev/TA)
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- BRL
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
What it pays out
8.8%more, and better covered, is higher, placed against 1,091 companies as of 2026-11-07
Dividend yield8.8%
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- BRL
- computed
Payout ratio64.5%
Common Dividends Paid / Net Income x 100, both from the latest filed fiscal year
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- BRL
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Dividend cover ratio2.5x
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- BRL
- computed
Share a finding
A link to the finding, not to you: it carries nothing about your account.